Stockreport

Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2025

Genmab A/S - American Depositary Shares  (GMAB) 
PDF Company Announcement Net sales of DARZALEX® in 2025 totaled USD 14,351 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity [Read more]